amiodarone has been researched along with Cardiomyopathies in 68 studies
Amiodarone: An antianginal and class III antiarrhythmic drug. It increases the duration of ventricular and atrial muscle action by inhibiting POTASSIUM CHANNELS and VOLTAGE-GATED SODIUM CHANNELS. There is a resulting decrease in heart rate and in vascular resistance.
amiodarone : A member of the class of 1-benzofurans that is 1-benzofuran substituted by a butyl group at position 2 and a 4-[2-(diethylamino)ethoxy]-3,5-diiodobenzoyl group at position 3. It is a cardiovascular drug used for the treatment of cardiac dysrhythmias.
Cardiomyopathies: A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS).
| Excerpt | Relevance | Reference |
|---|---|---|
| "A case is presented in which amiodarone was administered to suppress paroxysmal atrial fibrillation in a patient with an idiopathic cardiomyopathy." | 8.79 | Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate. ( Curwin, JH; Sachs, RG; Winters, SL, 1997) |
| " Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP)." | 8.02 | Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy. ( Enomoto, D; Hyodo, T; Ikeda, S; Okura, T; Sakaue, T; Takahashi, K; Takemoto, M; Uemura, S; Utsunomiya, Y; Yamashita, M, 2021) |
| "It is not known whether total thyroidectomy is more favorable than medical therapy for patients with amiodarone-induced thyrotoxicosis (AIT)." | 7.96 | Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis. ( Bartalena, L; Bogazzi, F; Cappellani, D; Di Certo, AM; Iervasi, G; Manetti, L; Mantuano, M; Marcocci, C; Marconcini, G; Martino, E; Materazzi, G; Morganti, R; Papini, P; Pingitore, A; Scattina, I; Tomisti, L; Urbani, C, 2020) |
| "Although amiodarone appears to have few pro-arrhythmic effects, torsade de pointes (TdP) has been observed during long-term drug administration, usually in conjunction with electrolyte disturbances, a change in drug dosage, or concomitant drug therapy." | 7.73 | Torsade de pointes induced by short-term oral amiodarone therapy. ( Ahn, JC; Kim, YH; Lim, HE; Pak, HN; Song, WH, 2006) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 7.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| "We observed sinoatrial block due to chronic amiodarone administration in a 5-year-old boy with primary cardiomyopathy, Wolff-Parkinson-White syndrome and supraventricular tachycardia." | 7.67 | Amiodarone-induced sinoatrial block. ( Berand, M; Davidson, E; Strasberg, B, 1985) |
| "Amiodarone can cause thyroid dysfunction in patients with or without previous thyroid disease." | 6.42 | Surgical management of amiodarone-induced thyrotoxicosis. ( Fan, CY; Franzese, CB; Stack, BC, 2003) |
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 5.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| "A case is presented in which amiodarone was administered to suppress paroxysmal atrial fibrillation in a patient with an idiopathic cardiomyopathy." | 4.79 | Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate. ( Curwin, JH; Sachs, RG; Winters, SL, 1997) |
| " Approximately 6 days after starting intravenous administration of amiodarone (600 mg/day) for maintaining sinus rhythm after cardioversion of AF, electrocardiograms revealed a prolonged QT interval associated with torsade de pointes (TdP)." | 4.02 | Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy. ( Enomoto, D; Hyodo, T; Ikeda, S; Okura, T; Sakaue, T; Takahashi, K; Takemoto, M; Uemura, S; Utsunomiya, Y; Yamashita, M, 2021) |
| "It is not known whether total thyroidectomy is more favorable than medical therapy for patients with amiodarone-induced thyrotoxicosis (AIT)." | 3.96 | Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis. ( Bartalena, L; Bogazzi, F; Cappellani, D; Di Certo, AM; Iervasi, G; Manetti, L; Mantuano, M; Marcocci, C; Marconcini, G; Martino, E; Materazzi, G; Morganti, R; Papini, P; Pingitore, A; Scattina, I; Tomisti, L; Urbani, C, 2020) |
| " A year later, he developed thyrotoxicosis, presumably secondary to amiodarone administered for ventricular fibrillation." | 3.79 | Thyrotoxicosis-facilitated bridge to recovery with a continuous-flow left ventricular assist device. ( Frazier, OH; Letsou, GV; Reverdin, S, 2013) |
| "The European Myocardial Infarct Amiodarone Trial (EMIAT) investigated the effects of amiodarone versus placebo in patients after myocardial infarction who had left ventricular ejection fraction | 3.73 | Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial). ( Badilini, F; Benchetrit, C; Coumel, P; Leenhardt, A; Maisonblanche, P; Milliez, P; Siliste, C; Vicaut, E, 2005) |
| "Although amiodarone appears to have few pro-arrhythmic effects, torsade de pointes (TdP) has been observed during long-term drug administration, usually in conjunction with electrolyte disturbances, a change in drug dosage, or concomitant drug therapy." | 3.73 | Torsade de pointes induced by short-term oral amiodarone therapy. ( Ahn, JC; Kim, YH; Lim, HE; Pak, HN; Song, WH, 2006) |
| " Data also suggest that amiodarone appears to be the safest antiarrhythmic drug for treatment sustained and nonsustained arrhythmias, and improved survival in patients with advanced heart failure." | 3.69 | [Pharmacologic treatment for ventricular arrhythmias]. ( Halawa, B, 1997) |
| "A group of 34 consecutive patients with coronary artery disease (n = 29) or dilated cardiomyopathy (n = 5) (3 women, 31 men, age 38-80 yr) who had severely impaired left ventricular function (left ventricular ejection fraction less than or equal to 40%) and high-grade ventricular ectopic activity (sustained or nonsustained ventricular tachycardia or ventricular fibrillation) were treated with amiodarone (mean dose: 206 mg/d) and followed for 1-117 (mean: 49) months." | 3.68 | Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction. ( Burckhardt, D; Hoffmann, A; Pfisterer, M; Robertson, A, 1991) |
| " Sustained rapid ventricular tachyarrhythmias requiring cardioversion for termination were induced by double right ventricular apical extrastimuli during control, and treatment with disopyramide, quinidine, and fluocortolone." | 3.67 | Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis. ( Belhassen, B; Laniado, S; Pines, A, 1989) |
| "We observed sinoatrial block due to chronic amiodarone administration in a 5-year-old boy with primary cardiomyopathy, Wolff-Parkinson-White syndrome and supraventricular tachycardia." | 3.67 | Amiodarone-induced sinoatrial block. ( Berand, M; Davidson, E; Strasberg, B, 1985) |
| "Procainamide therapy was associated with less major cardiac adverse events and a higher proportion of tachycardia termination within 40 min." | 2.84 | Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study. ( Almendral, J; Arribas, F; Coll-Vinent, B; Del Arco, C; Martín, A; Ortiz, M; Peinado, R, 2017) |
| "Recurrent ventricular tachycardia among survivors of myocardial infarction with an implantable cardioverter-defibrillator (ICD) is frequent despite antiarrhythmic drug therapy." | 2.82 | Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs. ( Blier, L; Essebag, V; Gula, L; Healey, JS; Leong-Sit, P; Nery, PB; Parkash, R; Raymond, JM; Redfearn, D; Rivard, L; Roux, JF; Sapp, JL; Sarrazin, JF; Sterns, LD; Stevenson, WG; Tang, AS; Thibault, B; Tung, SK; Veenhuyzen, GD; Wells, GA, 2016) |
| "Syncope was associated with increased mortality risk in SCD-HeFT regardless of treatment arm (placebo, amiodarone, or ICD)." | 2.73 | Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study. ( Anderson, J; Bardy, GH; Hellkamp, AS; Johnson, G; Lee, KL; Mark, DB; Olshansky, B; Packer, D; Poole, JE, 2008) |
| "Amiodarone can cause thyroid dysfunction in patients with or without previous thyroid disease." | 2.42 | Surgical management of amiodarone-induced thyrotoxicosis. ( Fan, CY; Franzese, CB; Stack, BC, 2003) |
| "Amiodarone is an effective and widely used antiarrhythmic drug with many possible adverse effects including hypercholesterolaemia and hepatotoxicity." | 1.48 | Desmosterol accumulation in users of amiodarone. ( Gylling, H; Kupari, M; Lampi, AM; Lehtonen, J; Piironen, V; Simonen, P; Stenman, UH, 2018) |
| " This combination involves a pharmacokinetic drug-drug interaction leading to subtherapeutic drug concentrations of amiodarone and its active metabolite." | 1.48 | Amiodarone Rifampicin Drug-Drug Interaction Management With Therapeutic Drug Monitoring. ( Demmer, A; Movig, KLL; Oude Munnink, TH; Slenter, RHJ, 2018) |
| "Dronedarone is a multichannel blocker with similar electrophysiological properties to amiodarone." | 1.37 | Suppression of ventricular tachycardia with dronedarone: a case report. ( Freudenberger, R; Levin, V; Marchlinski, FE; Shaaraoui, M, 2011) |
| "Among these arrhythmias, ventricular tachycardia may be resistant to treatment." | 1.30 | Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone. ( Kumbasar, SD; Paksoy, N; Semiz, E; Tosun, Z; Yalçinkaya, S, 1997) |
| " The dosage of amiodarone was reduced from 400 mg/day to 200 mg/day without reduction of mexiletine or disopyramide and the patient's symptoms diminished." | 1.30 | A case report of myolysis during high-dose amiodarone therapy for uncontrolled ventricular tachycardia. ( Hotta, N; Itoh, K; Kato, R, 1998) |
| "70% of cases) in hypertrophic cardiomyopathy is well recognized: episodes of ventricular tachycardia are present in 20% of cases and are related to an elevated risk of sudden death." | 1.27 | [Ambulatory ECG in cardiomyopathies]. ( Camerini, F; Di Lenarda, A; Mestroni, L; Miani, D; Neri, R, 1987) |
| "Amiodarone was given to 17 patients with drug refractory sustained ventricular arrhythmias." | 1.27 | Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness. ( Alpert, MA; Flaker, GC; Ruder, MA; Sanfelippo, JF; Tsutakawa, RK; Webel, RR, 1985) |
| "In the patients with a left bundle branch block morphology of VT (7 cases), four showed findings compatible with an arrhythmogenic right ventricular dysplasia or a right ventricular cardiomyopathy." | 1.27 | Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study. ( Alberti, E; Camerini, F; Morgera, T; Salvi, A; Silvestri, F, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 14 (20.59) | 18.7374 |
| 1990's | 12 (17.65) | 18.2507 |
| 2000's | 16 (23.53) | 29.6817 |
| 2010's | 21 (30.88) | 24.3611 |
| 2020's | 5 (7.35) | 2.80 |
| Authors | Studies |
|---|---|
| Arenal, Á | 1 |
| Ávila, P | 1 |
| Jiménez-Candil, J | 1 |
| Tercedor, L | 1 |
| Calvo, D | 1 |
| Arribas, F | 2 |
| Fernández-Portales, J | 1 |
| Merino, JL | 1 |
| Hernández-Madrid, A | 1 |
| Fernández-Avilés, FJ | 1 |
| Berruezo, A | 1 |
| Cappellani, D | 1 |
| Papini, P | 1 |
| Pingitore, A | 1 |
| Tomisti, L | 1 |
| Mantuano, M | 1 |
| Di Certo, AM | 1 |
| Manetti, L | 1 |
| Marconcini, G | 1 |
| Scattina, I | 1 |
| Urbani, C | 1 |
| Morganti, R | 1 |
| Marcocci, C | 1 |
| Materazzi, G | 1 |
| Iervasi, G | 1 |
| Martino, E | 1 |
| Bartalena, L | 1 |
| Bogazzi, F | 1 |
| Yonai, R | 1 |
| Kawabata, M | 1 |
| Maeda, S | 1 |
| Kawashima, T | 1 |
| Tsuda, Y | 1 |
| Nakasone, T | 1 |
| Nakane, H | 1 |
| Hirao, K | 1 |
| Di Biase, L | 1 |
| Romero, J | 1 |
| Du, X | 1 |
| Mohanty, S | 1 |
| Trivedi, C | 1 |
| Della Rocca, DG | 1 |
| Patel, K | 1 |
| Sanchez, J | 1 |
| Yang, R | 1 |
| Alviz, I | 1 |
| Mohanty, P | 1 |
| Gianni, C | 1 |
| Tarantino, N | 1 |
| Zhang, XD | 1 |
| Horton, R | 1 |
| Al-Ahmad, A | 1 |
| Lakkireddy, D | 1 |
| Burkhardt, DJ | 1 |
| Chen, M | 1 |
| Natale, A | 1 |
| Takahashi, K | 1 |
| Yamashita, M | 1 |
| Sakaue, T | 1 |
| Enomoto, D | 1 |
| Uemura, S | 1 |
| Okura, T | 1 |
| Ikeda, S | 1 |
| Takemoto, M | 1 |
| Utsunomiya, Y | 1 |
| Hyodo, T | 1 |
| Simonen, P | 1 |
| Lehtonen, J | 1 |
| Lampi, AM | 1 |
| Piironen, V | 1 |
| Stenman, UH | 1 |
| Kupari, M | 1 |
| Gylling, H | 1 |
| Oude Munnink, TH | 1 |
| Demmer, A | 1 |
| Slenter, RHJ | 1 |
| Movig, KLL | 1 |
| Liang, JJ | 1 |
| Yang, W | 1 |
| Santangeli, P | 1 |
| Schaller, RD | 1 |
| Supple, GE | 1 |
| Hutchinson, MD | 1 |
| Garcia, F | 1 |
| Lin, D | 1 |
| Dixit, S | 1 |
| Epstein, AE | 1 |
| Callans, DJ | 1 |
| Marchlinski, FE | 2 |
| Frankel, DS | 1 |
| Letsou, GV | 1 |
| Reverdin, S | 1 |
| Frazier, OH | 1 |
| Gao, D | 1 |
| Van Herendael, H | 1 |
| Alshengeiti, L | 1 |
| Dorian, P | 1 |
| Mangat, I | 1 |
| Korley, V | 1 |
| Ahmad, K | 1 |
| Golovchiner, G | 1 |
| Aves, T | 1 |
| Pinter, A | 1 |
| Piers, SR | 1 |
| Silva, Mde R | 1 |
| Kapel, GF | 1 |
| Trines, SA | 1 |
| Schalij, MJ | 1 |
| Zeppenfeld, K | 1 |
| Beckermann, TM | 1 |
| McLeod, K | 1 |
| Murday, V | 1 |
| Potet, F | 1 |
| George, AL | 1 |
| Amin, AS | 1 |
| Kaese, S | 1 |
| Schülke, C | 1 |
| Lebiedz, P | 1 |
| Ge, H | 2 |
| Li, X | 2 |
| Zhang, Y | 1 |
| Liu, H | 2 |
| Jiang, H | 2 |
| Sapp, JL | 1 |
| Wells, GA | 1 |
| Parkash, R | 1 |
| Stevenson, WG | 2 |
| Blier, L | 1 |
| Sarrazin, JF | 1 |
| Thibault, B | 1 |
| Rivard, L | 1 |
| Gula, L | 1 |
| Leong-Sit, P | 1 |
| Essebag, V | 1 |
| Nery, PB | 1 |
| Tung, SK | 1 |
| Raymond, JM | 1 |
| Sterns, LD | 1 |
| Veenhuyzen, GD | 1 |
| Healey, JS | 1 |
| Redfearn, D | 1 |
| Roux, JF | 1 |
| Tang, AS | 1 |
| Ortiz, M | 1 |
| Martín, A | 1 |
| Coll-Vinent, B | 1 |
| Del Arco, C | 1 |
| Peinado, R | 1 |
| Almendral, J | 1 |
| Yu, C | 1 |
| Zhu, TG | 1 |
| Liu, WL | 1 |
| Huang, WF | 1 |
| Bobbo, M | 1 |
| Pinamonti, B | 1 |
| Merlo, M | 1 |
| Stolfo, D | 1 |
| Iorio, A | 1 |
| Ramani, F | 1 |
| Barbati, G | 1 |
| Carriere, C | 1 |
| Massa, L | 1 |
| Poli, S | 1 |
| Scapol, S | 1 |
| Gigli, M | 1 |
| Di Lenarda, A | 2 |
| Sinagra, G | 1 |
| Catanzaro, JN | 1 |
| Makaryus, J | 1 |
| Vafai, J | 1 |
| Makaryus, AN | 1 |
| Jadonath, R | 1 |
| Beldner, S | 1 |
| Radulescu, B | 1 |
| Imperiale, A | 1 |
| Germain, P | 1 |
| Ohlmann, P | 1 |
| Britton, KA | 1 |
| Levy, BD | 1 |
| Katz, JT | 1 |
| Loscalzo, J | 1 |
| Shaaraoui, M | 1 |
| Freudenberger, R | 1 |
| Levin, V | 1 |
| Hsieh, YC | 1 |
| Huang, JL | 1 |
| Chin, CS | 1 |
| Lin, TC | 1 |
| Liao, YC | 1 |
| Ting, CT | 1 |
| Wu, TJ | 1 |
| Droogan, C | 1 |
| Patel, C | 1 |
| Yan, GX | 1 |
| Kowey, PR | 1 |
| Daidoji, H | 1 |
| Arimoto, T | 1 |
| Nitobe, J | 1 |
| Tamura, H | 1 |
| Kutsuzawa, D | 1 |
| Ishigaki, D | 1 |
| Ishino, M | 1 |
| Takahashi, H | 1 |
| Shishido, T | 1 |
| Miyashita, T | 1 |
| Miyamoto, T | 1 |
| Watanabe, T | 1 |
| Kubota, I | 1 |
| Kaneko, Y | 1 |
| Kurabayashi, M | 1 |
| Ermis, C | 1 |
| Zadeii, G | 1 |
| Zhu, AX | 1 |
| Fabian, W | 1 |
| Collins, J | 1 |
| Lurie, KG | 1 |
| Sakaguchi, S | 1 |
| Benditt, DG | 1 |
| Sweeney, MO | 1 |
| Franzese, CB | 1 |
| Fan, CY | 1 |
| Stack, BC | 1 |
| Andreu Rodríguez, AL | 1 |
| Morillas Blasco, P | 1 |
| García Aldabe, JJ | 1 |
| Bertomeu Martínez, V | 1 |
| Rodríguez Ortega, JA | 1 |
| Milliez, P | 1 |
| Leenhardt, A | 1 |
| Maisonblanche, P | 1 |
| Vicaut, E | 1 |
| Badilini, F | 1 |
| Siliste, C | 1 |
| Benchetrit, C | 1 |
| Coumel, P | 2 |
| Salamé, E | 1 |
| Osta, H | 1 |
| Antonios, S | 1 |
| Abdel-Massih, T | 1 |
| Gerbaka, B | 1 |
| Kassab, R | 1 |
| Bridgman, PG | 1 |
| Lim, HE | 1 |
| Pak, HN | 1 |
| Ahn, JC | 1 |
| Song, WH | 1 |
| Kim, YH | 1 |
| Komamura, K | 1 |
| Mori, M | 1 |
| Hanon, S | 1 |
| Rachko, M | 1 |
| Olshansky, B | 1 |
| Poole, JE | 1 |
| Johnson, G | 1 |
| Anderson, J | 1 |
| Hellkamp, AS | 1 |
| Packer, D | 1 |
| Mark, DB | 1 |
| Lee, KL | 1 |
| Bardy, GH | 1 |
| Milei, J | 1 |
| Garcilazo, E | 1 |
| Bolomo, NJ | 1 |
| Molina, HA | 1 |
| Steinbeck, G | 1 |
| Sung, RJ | 1 |
| Shen, EN | 1 |
| Morady, F | 1 |
| Scheinman, MM | 1 |
| Hess, D | 1 |
| Botvinick, EH | 1 |
| Mestroni, L | 2 |
| Fonda, F | 1 |
| Camerini, F | 3 |
| Vitolo, E | 1 |
| Tronci, M | 1 |
| Larovere, MT | 1 |
| Rumolo, R | 1 |
| Chen, RP | 1 |
| Ignaszewski, AP | 1 |
| Robertson, MA | 1 |
| Yalçinkaya, S | 1 |
| Kumbasar, SD | 1 |
| Semiz, E | 1 |
| Tosun, Z | 1 |
| Paksoy, N | 1 |
| Winters, SL | 1 |
| Sachs, RG | 1 |
| Curwin, JH | 1 |
| Halawa, B | 1 |
| Itoh, K | 1 |
| Kato, R | 1 |
| Hotta, N | 1 |
| Hara, M | 1 |
| Matsumori, A | 1 |
| Laurenzi, F | 1 |
| Avella, A | 1 |
| Adinolfi, E | 1 |
| Dini, P | 1 |
| Copie, X | 1 |
| Piot, O | 1 |
| Said, MA | 1 |
| Lavergne, T | 1 |
| Ollitrault, J | 1 |
| Guize, L | 1 |
| Le Heuzey, JY | 1 |
| Huikuri, HV | 1 |
| Castellanos, A | 1 |
| Myerburg, RJ | 1 |
| Villain, E | 2 |
| Bonnet, D | 2 |
| Attali, T | 1 |
| Da Cruz, E | 1 |
| Marchal, C | 1 |
| Gournay, V | 1 |
| Kachaner, J | 2 |
| Gill, J | 1 |
| Heel, RC | 1 |
| Fitton, A | 1 |
| Antiuf'ev, VF | 1 |
| Arkhipov, MV | 1 |
| Burckhardt, D | 1 |
| Robertson, A | 1 |
| Hoffmann, A | 1 |
| Pfisterer, M | 1 |
| Le Bidois, J | 1 |
| Cohen, L | 1 |
| Piéchaud, JF | 1 |
| Sidi, D | 1 |
| Leclercq, JF | 1 |
| Belhassen, B | 1 |
| Pines, A | 1 |
| Laniado, S | 1 |
| McKenna, WJ | 1 |
| Miani, D | 1 |
| Neri, R | 1 |
| Kracoff, OH | 1 |
| Ovsyshcher, I | 1 |
| Gueron, M | 1 |
| Mitova, M | 1 |
| Bednarík, B | 1 |
| Lupínek, Z | 1 |
| Cerný, E | 1 |
| Strasberg, B | 1 |
| Davidson, E | 1 |
| Berand, M | 1 |
| Flaker, GC | 1 |
| Alpert, MA | 1 |
| Webel, RR | 1 |
| Ruder, MA | 1 |
| Sanfelippo, JF | 1 |
| Tsutakawa, RK | 1 |
| Morgera, T | 1 |
| Salvi, A | 1 |
| Alberti, E | 1 |
| Silvestri, F | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Randomized Controlled Phase IV Multicentric Trial, Comparing the Efficacy and Safety of Radiofrequency Substrate Ablation of Monomorphic Ventricular Tachycardia vs. Antiarrhyhtmic Drugs in Patients Experiencing Appropriate ICD Shocks[NCT03734562] | 180 participants (Actual) | Interventional | 2010-07-31 | Completed | |||
| Endocardial-Epicardial Radiofrequency Ablation of Ventricular Tachycardia in Patients With Ischemic Cardiomyopathy[NCT04512911] | Early Phase 1 | 0 participants (Actual) | Interventional | 2023-01-31 | Withdrawn (stopped due to IRB approval expired 1/23/2023 and eclipsed the 6 month institutional window where study can be reinitiated via progress report. No enrollment has taken place.) | ||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT03819504] | 0 participants (Actual) | Interventional | 2018-08-01 | Withdrawn (stopped due to Change in the design of the study) | |||
| Phase I/II Study of 4-D Navigated Non-invasive Radiosurgical Ablation of Ventricular Tachycardia[NCT03601832] | 10 participants (Actual) | Interventional | 2018-08-01 | Completed | |||
| VOYAGE- Ventricular Tachycardia Ablation and Myocardial Scar Characterization With Magnetic Resonance[NCT04694079] | Phase 3 | 103 participants (Anticipated) | Interventional | 2020-08-03 | Recruiting | ||
| STereotactic Ablative Radiosurgery of Recurrent Ventricular Tachycardia in Structural Heart Disease[NCT04612140] | 100 participants (Actual) | Interventional | 2020-10-01 | Completed | |||
| Ventricular Tachycardia Ablation or Escalated aNtiarrhythmic Drugs in ISchemic Heart Disease[NCT00905853] | Phase 4 | 260 participants (Actual) | Interventional | 2009-05-31 | Completed | ||
| Repeated Endocardial Mapping for Efficacy Assessment After Catheter Ablation for Ischemic Ventricular Tachycardia[NCT05713357] | 20 participants (Anticipated) | Observational | 2023-03-15 | Enrolling by invitation | |||
| Initial Management of Patients Receiving a Single Shock (IMPRESS)[NCT03531502] | 30 participants (Actual) | Interventional | 2018-04-09 | Terminated (stopped due to lack of funding) | |||
| Preventive VT Substrate Ablation in Patients With Chronic Post-MI Scar Showing Arrhythmogenic Characteristics[NCT04675073] | Phase 3 | 58 participants (Anticipated) | Interventional | 2021-06-01 | Recruiting | ||
| [NCT00000609] | Phase 3 | 0 participants | Interventional | 1997-05-31 | Completed | ||
| Characterization of Cardiac Arrhythmias in End Stage Kidney Disease Patients on Hemodialysis Using an Implantable Continuous Cardiac Rhythm Monitoring Device: A Pilot Study[NCT00932659] | 8 participants (Actual) | Observational | 2009-06-30 | Completed | |||
| Comparative Effectiveness Research to Assess the Use of Primary ProphylacTic Implantable Cardioverter Defibrillators in Europe[NCT02064192] | 2,285 participants (Actual) | Observational | 2014-05-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
(NCT00932659)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Single Arm: Hemodialysis Patients Implanted With REVEAL Device | 0 |
(NCT00932659)
Timeframe: 6 months
| Intervention | participants (Number) |
|---|---|
| Single Arm: Hemodialysis Patients Implanted With REVEAL Device | 0 |
9 reviews available for amiodarone and Cardiomyopathies
| Article | Year |
|---|---|
Role of antiarrhythmic drugs: frequent implantable cardioverter-defibrillator shocks, risk of proarrhythmia, and new drug therapy.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Death, Sudden, Ca | 2011 |
[Arrhythmias in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death, Sudden, Cardiac; | 2002 |
Surgical management of amiodarone-induced thyrotoxicosis.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; M | 2003 |
[Tachycardia-induced cardiomyopathy].
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter A | 2007 |
Successful treatment of supraventricular tachycardia-induced cardiomyopathy with amiodarone: case report and review of literature.
Topics: Adult; Amiodarone; Cardiomyopathies; Electrocardiography; Female; Fetal Diseases; Humans; Infant, Ne | 1995 |
Nonsustained polymorphous ventricular tachycardia during amiodarone therapy for atrial fibrillation complicating cardiomyopathy. Management with intravenous magnesium sulfate.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Humans; Infusions, | 1997 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Sudden death due to cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Baroreflex; C | 2001 |
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.
Topics: Amiodarone; Animals; Arrhythmias, Cardiac; Cardiomyopathies; Drug Interactions; Heart Conduction Sys | 1992 |
[Incessant idiopathic ventricular tachycardia in infants].
Topics: Amiodarone; Cardiomyopathies; Child, Preschool; Electrocardiography; Female; Flecainide; Follow-Up S | 1990 |
4 trials available for amiodarone and Cardiomyopathies
| Article | Year |
|---|---|
Substrate Ablation vs Antiarrhythmic Drug Therapy for Symptomatic Ventricular Tachycardia.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2022 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Ventricular Tachycardia Ablation versus Escalation of Antiarrhythmic Drugs.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Defibrillators, Impla | 2016 |
Randomized comparison of intravenous procainamide vs. intravenous amiodarone for the acute treatment of tolerated wide QRS tachycardia: the PROCAMIO study.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Drug Administration Schedule; Female; Hu | 2017 |
Syncope predicts the outcome of cardiomyopathy patients: analysis of the SCD-HeFT study.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Death, Sudden, Cardiac; Defibrillators, | 2008 |
55 other studies available for amiodarone and Cardiomyopathies
| Article | Year |
|---|---|
Comparison Between Total Thyroidectomy and Medical Therapy for Amiodarone-Induced Thyrotoxicosis.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cohort Studies; Female; Glucocorticoids; | 2020 |
Torsade de pointes induced by intravenous amiodarone therapy accompanied by marked augmentation of the transmural dispersion of repolarization in a patient with tachycardia-induced-cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Electrocardiography; Humans; Male; Torsa | 2021 |
Catheter ablation of ventricular tachycardia in ischemic cardiomyopathy: Impact of concomitant amiodarone therapy on short- and long-term clinical outcomes.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Female; Follow-Up Stu | 2021 |
Suppression of amiodarone-induced torsade de pointes by landiolol in a patient with atrial fibrillation-mediated cardiomyopathy.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Electrocardiography | 2021 |
Desmosterol accumulation in users of amiodarone.
Topics: Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiac Imaging Techniques; Cardiomyopathies; Cholestero | 2018 |
Amiodarone Rifampicin Drug-Drug Interaction Management With Therapeutic Drug Monitoring.
Topics: Aged; Amiodarone; Cardiomyopathies; Cytochrome P-450 CYP3A; Drug Interactions; Drug Monitoring; Huma | 2018 |
Amiodarone Discontinuation or Dose Reduction Following Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Case-Control Studies; Catheter Ablation; Drug | 2017 |
Thyrotoxicosis-facilitated bridge to recovery with a continuous-flow left ventricular assist device.
Topics: Amiodarone; Cardiomyopathies; Heart-Assist Devices; Humans; Male; Thyrotoxicosis; Ventricular Fibril | 2013 |
Mexiletine as an adjunctive therapy to amiodarone reduces the frequency of ventricular tachyarrhythmia events in patients with an implantable defibrillator.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cohort Studies | 2013 |
Endocardial or epicardial ventricular tachycardia in nonischemic cardiomyopathy? The role of 12-lead ECG criteria in clinical practice.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Cerebral Palsy; Electrocardiography; Ele | 2014 |
Novel SCN5A mutation in amiodarone-responsive multifocal ventricular ectopy-associated cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; DNA; DNA Mutational Analysis; Electrocardiogra | 2014 |
SCN5A-related dilated cardiomyopathy: what do we know?
Topics: Amiodarone; Cardiomyopathies; DNA; Female; Humans; Male; Mutation; NAV1.5 Voltage-Gated Sodium Chann | 2014 |
Thyrotoxic cardiomyopathy with recurrent ventricular fibrillation and multi-organ failure.
Topics: Amiodarone; Anti-Arrhythmia Agents; Antithyroid Agents; Cardiomyopathies; Cardiopulmonary Resuscitat | 2014 |
[Clinical course and treatment of ectopic atrial tachycardia in 144 children].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Catheter Ablation; Child; Child, Preschool; Ec | 2015 |
Left-dominant Arrhythmogenic Cardiomyopathy: A Case Misdiagnosed as Pseudoaneurysm.
Topics: Amiodarone; Aneurysm, False; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Humans; | 2016 |
Predictors of Pharmacological Therapy of Ectopic Atrial Tachycardia in Children.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Child; Child, Preschool; China; Drug Therapy, | 2017 |
Comparison of Patient Characteristics and Course of Hypertensive Hypokinetic Cardiomyopathy Versus Idiopathic Dilated Cardiomyopathy.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin Receptor Antagonists; Angiotensin- | 2017 |
I was told to stop taking my daily betablocker (Coreg)before a myocardial perfusion test. I was hospitalized with chest pain and a bout of atrial fibrillation. I have cardiomyopathy and was prescribed amiodarone and warfarin, but I stopped taking them w
Topics: Adrenergic beta-Antagonists; Amiodarone; Anticoagulants; Atrial Fibrillation; Cardiomyopathies; Ches | 2008 |
Dual atrioventricular-nodal physiology, elicited by pacing and leading to a reversible cardiomyopathy.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrioventricular Node; Cardiac Pacing, Arti | 2009 |
Severe ventricular arrhythmias in a patient with cardiac sarcoidosis: insights from MRI and PET imaging and importance of early corticosteroid therapy.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantable; Humans; Hy | 2010 |
Clinical problem-solving. The beat goes on.
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrioventricular Block; Biopsy; Cardiomyopathies; Diagnosis, Dif | 2010 |
Suppression of ventricular tachycardia with dronedarone: a case report.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Dronedarone; Humans; Male; Secondary Pr | 2011 |
Pre-clinical detection of amiodarone-induced acute fibrosing alveolitis by intra-thoracic impedance monitor of an implantable cardioverter-defibrillator.
Topics: Acute Disease; Aged; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantab | 2011 |
Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopa | 2012 |
Improved survival of cardiac transplantation candidates with implantable cardioverter defibrillator therapy: role of beta-blocker or amiodarone treatment.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 2003 |
A bridge, but to where?
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 2003 |
[Recent beginning atrial fibrillation].
Topics: Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiomyopathies; Echocardiography, Doppler | 2004 |
Usefulness of ventricular repolarization dynamicity in predicting arrhythmic deaths in patients with ischemic cardiomyopathy (from the European Myocardial Infarct Amiodarone Trial).
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Death; Electrocard | 2005 |
[Chaotic atrial tachycardia-induced cardiomyopathy: report of an isolated case].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Female; Humans; Infant, Newborn; Recurrence; T | 2005 |
Late presentation of a cardiomyopathy provoked by sudden emotional stress.
Topics: Acute Disease; Adult; Amiodarone; Cardiomyopathies; Contraindications; Female; Humans; Stress, Psych | 2006 |
Torsade de pointes induced by short-term oral amiodarone therapy.
Topics: Administration, Oral; Adult; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Fibrillat | 2006 |
Case report: Cardiac sarcoidosis presenting with ventricular arrhythmias: case report and review of the literature.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Defibrillators, Implantable; Diagnosis, Differ | 2007 |
Effects of lorcainide and amiodarone on stress-induced myocardial damage in the rat.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Benzofurans; Cardiomyopathies; Femal | 1984 |
[33-year-old patient with severe ventricular heart rhythm disorders].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Electroencephalography; Heart Failure; He | 1982 |
Electrophysiologic mechanism of exercise-induced sustained ventricular tachycardia.
Topics: Adolescent; Adult; Aged; Amiodarone; Cardiomyopathies; Catecholamines; Coronary Disease; Electrophys | 1983 |
Ventricular arrhythmias in congestive cardiomyopathy.
Topics: Amiodarone; Arrhythmias, Cardiac; Cardiomyopathies; Heart Failure; Heart Ventricles; Humans | 1983 |
[Comparison of the effectiveness of amiodarone and quinidine in the prevention of arrhythmia].
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Atrial Fibrillation; Benzofurans; Cardiomyopathies; Female; | 1980 |
Sustained ventricular tachycardia in cardiac hemochromatosis treated with amiodarone.
Topics: Adolescent; Amiodarone; Anti-Arrhythmia Agents; Biopsy; Cardiomyopathies; Electrocardiography; Hemoc | 1997 |
[Pharmacologic treatment for ventricular arrhythmias].
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Heart Failure; Humans; Recur | 1997 |
A case report of myolysis during high-dose amiodarone therapy for uncontrolled ventricular tachycardia.
Topics: Adult; Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Humans; Male; Muscle, Skeletal; Pain; S | 1998 |
[Impaired left ventricular function in a patient with visual disturbance].
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Female; Humans; Sa | 1998 |
[Role of electrophysiology in the prognosis and therapy of cardiomyopathies].
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopath | 1999 |
Temporal and geographical trends in indications for implantation of cardiac defibrillators in Europe 1993-1998. Medtronic ICD System Investigators.
Topics: Amiodarone; Anti-Arrhythmia Agents; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardiac; Defi | 2000 |
[Rhythmogenic cardiomyopathies of atrial origin in children. Myth or reality?].
Topics: Adrenergic beta-Antagonists; Amiodarone; Cardiomyopathies; Child; Chronic Disease; Electrocardiograp | 1992 |
[The characteristics of the chronotropic and anti-arrhythmia effects of kordaron].
Topics: Adolescent; Adult; Amiodarone; Cardiac Complexes, Premature; Cardiomyopathies; Drug Evaluation; Fema | 1990 |
Long-term treatment of ventricular tachycardia with amiodarone in presence of severe left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Amiodarone; Cardiomyopathies; Coronary Disease; Death, Sudden, Cardi | 1991 |
Characteristics, prognosis and treatment of the ventricular arrhythmias of right ventricular dysplasia.
Topics: Adrenergic beta-Antagonists; Adult; Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardio | 1989 |
Failure of corticosteroid therapy to prevent induction of ventricular tachycardia in sarcoidosis.
Topics: Adult; Amiodarone; Cardiac Pacing, Artificial; Cardiomyopathies; Disopyramide; Drug Therapy, Combina | 1989 |
Amiodarone and the cardiomyopathies.
Topics: Adult; Amiodarone; Arrhythmias, Cardiac; Benzofurans; Cardiomyopathies; Cardiomyopathy, Dilated; Car | 1986 |
[Ambulatory ECG in cardiomyopathies].
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiomyopathies; Cardiomyopathy, Dilated; | 1987 |
Malignant course of a benign anomaly: myocardial bridging.
Topics: Adult; Amiodarone; Cardiomyopathies; Coronary Angiography; Diltiazem; Electrocardiography; Electroph | 1987 |
The effect of cordarone on isoproterenol-induced damage to the myocardium in rats.
Topics: Amiodarone; Animals; Benzofurans; Cardiomyopathies; Isoproterenol; Male; Necrosis; Rats; Rats, Inbre | 1986 |
Amiodarone-induced sinoatrial block.
Topics: Amiodarone; Benzofurans; Cardiomyopathies; Child, Preschool; Dose-Response Relationship, Drug; Elect | 1985 |
Amiodarone and sustained ventricular arrhythmias: statistical evidence of drug effectiveness.
Topics: Aged; Amiodarone; Anti-Arrhythmia Agents; Benzofurans; Cardiomyopathies; Coronary Disease; Drug Resi | 1985 |
Morphological findings in apparently idiopathic ventricular tachycardia. An echocardiographic haemodynamic and histologic study.
Topics: Adult; Aged; Amiodarone; Biopsy; Bundle-Branch Block; Cardiomyopathies; Drug Therapy, Combination; E | 1985 |